ANCA-associated glomerulonephritis (ANCA-GN) is an immune-mediated kidney disease leading to acute or chronic renal failure. This study investigates the role of mitophagy-related genes in ANCA-GN, as mitochondrial dysfunction is closely linked to the pathogenesis of various kidney diseases. This study analyzed transcriptomic data from GEO datasets (GSE104948 and GSE108109) to investigate mitophagy-related mechanisms in ANCA-GN. Methods included batch correction, consensus clustering (identifying two subtypes), weighted gene co-expression network analysis (WGCNA), differential expression screening, and machine learning (LASSO, random forest, SVM-RFE). A diagnostic nomogram was constructed and validated, and immune cell infiltration was profiled. Analyses revealed distinct activation of immune pathways, including complement and phagosome signaling, alongside abnormal infiltration of CD8+ T cells in ANCA-GN. Subtype-specific analysis identified 131 differentially expressed genes (DEGs), while 143 DEGs distinguished ANCA-GN from controls.Intersection analysis and machine learning prioritized two hub genes, PYCARD and IFI30, which exhibited strong diagnostic accuracy (AUC >0.9) and correlated with CD8+ T-cell infiltration. A nomogram model validated their clinical utility (AUC >0.9). Functional enrichment highlighted phagocytosis and immune signaling pathways. Immune profiling revealed significant upregulation of 20 immune cell types in ANCA-GN. These findings suggest that mitophagy-immune crosstalk drives ANCA-GN progression, with PYCARD and IFI30 as potential diagnostic biomarkers. This study provides mechanistic insights into ANCA-GN pathogenesis and proposes novel targets for clinical intervention.
Ankylosing spondylitis (AS), strongly linked to human leukocyte antigen (HLA)-B27, lacks effective treatments for many patients despite biologics. This study investigated causal links between immune cells, inflammatory proteins, and AS to identify new therapeutic targets using genetic methods. Mendelian randomization (MR) analysis was applied using large-scale genetic data. Immune cell data came from Vuckovic et al and Orrù et al, AS data from FinnGen, and inflammatory protein data from Zhao et al. Two-sample MR explored causal relationships, and mediation analysis assessed whether proteins mediated immune cell effects on AS. MR analysis identified 26 immune cell phenotypes associated with AS, with HLA DR+ CD14− CD16+ monocytes showing the strongest protective effect (odds ratio = 0.6423). Among the 5 associated inflammatory proteins, C-C motif chemokine 19 (CCL19) had the most substantial effect on AS risk (odds ratio = 2.4234). Mediation analysis revealed that HLA DR+ CD14− CD16+ monocytes influence AS risk by reducing CCL19 levels, with the proportion of the mediated effect was 17.98% (95% confidence interval = 8.23%–27.72%). Our findings suggest that HLA DR+ CD14− CD16+ monocytes are associated with a reduced risk of AS, as indicated by a negative causal effect (β = −0.4426). This protective effect is partially mediated by a decrease in CCL19 levels, a chemokine that, when elevated, increases AS risk. These results identify CCL19 and this monocyte subset as potential key players in AS pathogenesis and highlight them as promising targets for more effective, personalized therapies.